Showing results (31-40 of 143) with videos related to
Sort By:
Pageof 15
Biorxiv : the Preprint Server for Biology|March 24, 2021
A novel soluble ACE2 protein totally protects from lethal disease caused by SARS-CoV-2 infectionLuise Hassler, Jan Wysocki, Ian Gelarden, et al.Kidney International|December 9, 2016
Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathyJan Wysocki, Minghao Ye, Ahmed M Khattab, et al.Journal of the American Society of Nephrology : JASN|February 2, 2021
A Novel Soluble ACE2 Variant with Prolonged Duration of Action Neutralizes SARS-CoV-2 Infection in Human Kidney OrganoidsJan Wysocki, Minghao Ye, Luise Hassler, et al.Kidney International|April 6, 2012
Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in miceRenisha Nadarajah, Rosangela Milagres, Marc Dilauro, et al.Hypertension (Dallas, Tex. : 1979)|July 11, 2012
Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2Minghao Ye, Jan Wysocki, Francisco R Gonzalez-Pacheco, et al.Kidney International Reports|December 12, 2022
Urinary Angiotensinogen in Patients With Type 1 Diabetes With Microalbuminuria: Gender Differences and Effect of Intensive Insulin TherapyJessica Navarro, Alejandro Sanchez, Sheeba H Ba Aqeel, et al.Kidney International|April 26, 2018
Novel ACE2-Fc chimeric fusion provides long-lasting hypertension control and organ protection in mouse models of systemic renin angiotensin system activationPan Liu, Jan Wysocki, Tomokazu Souma, et al.Cells|February 9, 2024
Soluble Angiotensin-Converting Enzyme 2 Protein Improves Survival and Lowers Viral Titers in Lethal Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection with the Delta VariantCosimo Cianfarini, Luise Hassler, Jan Wysocki, et al.Expert Opinion on Investigational Drugs|January 16, 2010
Targeted therapy of hepatocellular cancerPiotr Jan WysockiDiabetes|June 29, 2006
ACE and ACE2 activity in diabetic miceJan Wysocki, Minghao Ye, Maria José Soler, et al.Pageof 15